COMPASS Pathways plc (CMPS)

NMS – Real Time Price. Currency in USD

9.37

-0.28 (-2.90%)

At close: May 12, 2026, 4:00 PM EDT

9.49

+0.12 (1.32%)

After-hours: May 12, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

COMPASS Pathways plc (CMPS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

COMPASS Pathways plc (CMPS)

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These 3 Psychedelic Stocks Activated After Trump's Executive Order

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136%

Videos

No Data

Press releases

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026

Search stocks

COMPASS Pathways plc (CMPS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

COMPASS Pathways plc (CMPS)

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These 3 Psychedelic Stocks Activated After Trump's Executive Order

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136%

Videos

No Data

Press releases

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026